Literature DB >> 16713423

Large renal angiomyolipomas: digital subtraction angiographic grading and presentation with bleeding.

U Rimon1, M Duvdevani, A Garniek, G Golan, P Bensaid, J Ramon, B Morag.   

Abstract

AIM: To investigate whether a grading system of renal AMLs based on digital subtraction angiography (DSA) and computerized tomography (CT), could help to select patients for embolization.
MATERIALS AND METHODS: Thirty patients with 35 renal angiomyolipomas (size range 4-20 cm, mean 9.9 cm) underwent both digital subtraction angiography (DSA) and computed tomography (CT). Based on the DSA appearance the tumours were graded into three grades: grade I, minimal vascularity; grade II, moderate vascularity; grade III, marked vascularity.
RESULTS: There were seven grade I (mean 9.3 cm, range 4.5-20 cm), 18 grade II (mean 8.9 cm, range 5-18 cm) and 10 grade III tumours (mean 12.1 cm, range 4-20 cm). Five grade I tumours did not cause symptoms (71%) and two caused flank pain and haematuria, respectively (14.3% each). Nine of the grade II tumours were asymptomatic (50%), seven caused bleeding (39%) and two caused flank pain (11%). Four grade III tumours were asymptomatic (40%), five caused bleeding (50%) and one pain (10%).
CONCLUSIONS: According to our criteria, large angiomyolipomas with minimal vascularity are less likely to bleed, and do not need prophylactic treatment. This needs to be confirmed in larger studies.

Entities:  

Mesh:

Year:  2006        PMID: 16713423     DOI: 10.1016/j.crad.2006.02.003

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  22 in total

1.  Trans-Radial Embolization of Bleeding Renal Angiomyolipoma in Pregnant 30-Year-Old Female - A Case Report.

Authors:  Zachary Scharf; Ifechi Momah-Ukeh; Alexander Y Kim
Journal:  J Radiol Case Rep       Date:  2019-02-28

2.  Clinical presentation, management, and outcome of patients with incidental renal angiomyolipoma in qatar.

Authors:  Hassan Al-Thani; Ayman El-Menyar; Maryam Al-Sulaiti; Jamela El-Mabrok; Khairi Hajaji; Hesham Elgohary; Ahmed Al-Malki; Abdelhakem Tabeb
Journal:  Oman Med J       Date:  2014-11

3.  Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction.

Authors:  Florian Bardin; Olivier Chevallier; Aurélie Bertaut; Emmanuel Delorme; Morgan Moulin; Pierre Pottecher; Lucy Di Marco; Sophie Gehin; Eric Mourey; Luc Cormier; Christiane Mousson; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2017-02

Review 4.  The Role of Interventional Radiology Techniques in the Management of Renal Angiomyolipomas.

Authors:  Ryan M Kiefer; S William Stavropoulos
Journal:  Curr Urol Rep       Date:  2017-05       Impact factor: 3.092

5.  Can we predict the existence of extrarenal feeders to renal angiomyolipomas?

Authors:  Xixi Zhang; Ryohei Kuwatsuru; Hiroshi Toei; Daiske Yashiro; Shingo Okada; Hitomi Kato
Journal:  Eur Radiol       Date:  2018-12-12       Impact factor: 5.315

6.  Renal artery embolization.

Authors:  Steven Sauk; Darryl A Zuckerman
Journal:  Semin Intervent Radiol       Date:  2011-12       Impact factor: 1.513

Review 7.  Evidence-based protocol-led management of renal angiomyolipoma: A review of literature.

Authors:  Sophie Vaggers; Patrick Rice; Bhaskar K Somani; Rajan Veeratterapillay; Bhavan P Rai
Journal:  Turk J Urol       Date:  2020-09-21

8.  Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis.

Authors:  Rahul A Sheth; Adam S Feldman; Elahna Paul; Elizabeth A Thiele; T Gregory Walker
Journal:  World J Radiol       Date:  2016-03-28

9.  Renal artery embolization in a gross kidney neoplasm. Case report.

Authors:  G Provenza; A Sparagna; G V Cunsolo; S M Tierno; F Centanini; C Bellotti; G Mezzetti
Journal:  G Chir       Date:  2013 Sep-Oct

Review 10.  MRI phenotype in renal cancer: is it clinically relevant?

Authors:  Naomi Campbell; Andrew B Rosenkrantz; Ivan Pedrosa
Journal:  Top Magn Reson Imaging       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.